Africa CDC AVMI Fellowship 2026-2027: Fully Funded Vaccine Training
The Africa CDC and African Vaccine Manufacturing Initiative (AVMI) Industrial Fellowship Programme 2026-2027 offers a fully funded chance for recent African graduates to train in vaccine manufacturing. This one-year program helps build skills needed to boost Africa’s vaccine production. It targets young professionals ready to make a difference in public health.
Background and Rationale
Africa needs more experts in vaccine manufacturing to meet future demands. By 2040, the continent will require about 12,500 full-time workers in this field. Right now, only 2,000 to 3,000 people fill these roles, and many lack full training.
Past training programs from other countries cost too much and face issues like visas. Africa also lacks enough local spots for hands-on practice. That is why Africa CDC teamed up with AVMI to create this fellowship. It trains Africans in Africa for real industry work.
About the Industrial Fellowship Programme
This program runs for one year and follows Africa CDC’s standards for vaccine research, development, and manufacturing skills. Fellows work in vaccine factories in Egypt, Senegal, or South Africa. They learn current Good Manufacturing Practices, or cGMP, which match global rules.
Key Features
- Duration: July 2026 to September 2027
- Placement locations: Egypt, Senegal, or South Africa
- Focus: Vaccine manufacturing and cGMP
- Cohort size: Just 14 fellows selected
What the Fellowship Offers
Fellows get full support to focus on training without money worries.
Financial Support
The program covers return flights to the host country, visa fees, and paperwork help. It also provides a stipend for daily needs.
Hands-On Industry Experience
Trainees work in real vaccine plants. They see pharmaceutical production up close and follow global standards.
Career Development
Fellows build technical skills and boost their job chances in vaccine manufacturing. They help advance Africa’s health systems.
Fields of Study Eligible
You need a background in one of these areas:
- Pharmacy and Pharmaceutical Sciences
- Pharmaceutical Biotechnology
- Chemistry or Biochemistry
- Chemical Engineering
- Biomanufacturing or Vaccine Manufacturing
Eligibility Criteria
To apply, you must:
- Be a citizen of an African Union member state
- Have graduated in the last 3 years with a Bachelor’s or Master’s degree
- Hold a valid passport
- Be free to join in Egypt, Senegal, or South Africa
- Speak English or French well
The program welcomes all qualified people. It encourages women to apply.
Selection Process
A committee from Africa CDC, PHAHM, and AVMI reviews applications. Only shortlisted candidates hear back. They pick 14 fellows total.
Application Timeline
- Deadline: April 30, 2026
- Selection notices: May 15, 2026
- Program dates: July 2026 to September 2027
Apply early for a better shot.
How to Apply
Fill out the official form here: Apply for the Africa CDC Industrial Fellowship Programme.
Learn more about the program here.
Why You Should Apply
This fellowship gives rare access to vaccine manufacturing training in Africa. You gain key skills in a growing field, help secure Africa’s health future, and open doors in biotech and pharma jobs. Join the next wave of leaders.
Conclusion
The Africa CDC & AVMI Industrial Fellowship Programme 2026-2027 equips African graduates with vital vaccine manufacturing skills. It supports Africa’s goal of self-reliance in health. Apply now to be part of this change.
SHARE THIS POST WITH OTHERS
Frequently Asked Questions
Who is eligible for the fellowship?
African Union citizens who graduated in the last 3 years with a Bachelor’s or Master’s in pharmacy, biotech, chemistry, engineering, or related fields, and who speak English or French.
What does the program cover financially?
It provides return flights, visa fees, paperwork help, and a stipend for daily needs.
Where do fellows train?
In real vaccine manufacturing plants in Egypt, Senegal, or South Africa.
When is the application deadline?
April 30, 2026; the program starts in July 2026 and ends in September 2027.